- Amneal Pharmaceuticals (NYSE:AMRX) shares rise nearly 5% premarket after posting fourth-quarter revenue that beat Wall Street estimates, helped by its AvKARE acquisition and new product launches.
- Net revenue in the fourth quarter of 2020 was $510M, an increase of 28% compared to $397M in the
Amneal shares rise after Q4 results, FY forecast
Recommended For You
More Trending News
About AMRX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| AMRX | - | - |
| Amneal Pharmaceuticals, Inc. | ||